Venous thromboembolic events (VTE) in patients treated with cisplatin as compared to carboplatin-containing regimens

被引：0
|
作者：
Dixit, N.
Ijaz, A.
Martin, L. A.
Lee, M. H.
机构：
[1] Caritas St Elizabeth Med Ctr, Boston, MA USA
[2] Tufts Univ, Sch Med, Dept Med, Caritas St Elizabeth Med Ctr, Boston, MA 02111 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e19679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19679
引用
收藏
页数：1
相关论文
共 50 条
  • [41] VENOUS THROMBOEMBOLIC EVENTS IN GLIOBLASTOMA PATIENTS: AN EPIDEMIOLOGICAL VIEW
    Gramatzki, Dorothee
    Roth, Patrick
    Le Rhun, Emilie
    Rushing, Elisabeth
    Rohrmann, Sabine
    Stahel, Rolf
    Weller, Michael
    NEURO-ONCOLOGY, 2019, 21 : 76 - 76
  • [42] A prospective study on the incidence of delayed nausea and vomiting following administration of carboplatin-containing regimens for treatment of cancer without prophylactic aprepitant
    Pflederer, C.
    Goodgame, B. W.
    Morgensztern, D.
    Gao, F.
    Govindan, R.
    Baggstrom, M. Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] High Incidence of Thromboembolic Events in Patients Treated With Cisplatin-Based Chemotherapy: A Large Retrospective Analysis
    Moore, Russell A.
    Adel, Nelly
    Riedel, Elyn
    Bhutani, Manisha
    Feldman, Darren R.
    Tabbara, Nour Elise
    Soff, Gerald
    Parameswaran, Rekha
    Hassoun, Hani
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) : 3466 - 3473
  • [44] Recurrent Venous Thromboembolic Events in Granulomatosis with Polyangiitis Patients
    Nevares, Alana
    Messner, William
    Tamaki, Hiromichi
    Kinanah, Yaseen
    Villa-Forte, Alexandra
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [45] Characterization of venous thromboembolic events (VTE), elevated aminotransferases (EAT) and interstitial lung disease (ILD) in monarchE
    Toi, M.
    Harbeck, N.
    Puig, J. M.
    Cruz, J.
    Seo, J. H.
    Takahashi, M.
    Hulstijn, M.
    Twum, E. A.
    Regev, A.
    San Antonio, B.
    Median, D. M.
    Campone, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S39 - S40
  • [46] 2 CARBOPLATIN-CONTAINING REGIMENS FOR SMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS OF A RANDOMIZED PHASE-II TRIAL
    POSTMUS, PE
    KIRKPATRICK, A
    DALESIO, O
    PALMEN, FJ
    CARNEY, DN
    FESTEN, J
    VENDRIK, C
    ROOZENDAAL, K
    BURGHOUTS, J
    PLANTING, A
    QUOIX, E
    SPLINTER, TAW
    MCVIE, JG
    CANCER TREATMENT REVIEWS, 1988, 15 : 41 - 44
  • [47] Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
    Shields, Lisa B. E.
    Daniels, Michael W.
    Mar, Nataliya
    Rezazadeh Kalebasty, Arash
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (03): : 183 - 194
  • [48] Prevention of venous thromboembolic events occurring in myeloma patients treated with second-generation novel agents
    Santoro, Marco
    Romano, Alessandra
    Mancuso, Salvatrice
    Siragusa, Sergio
    Di Raimondo, Francesco
    Martinelli, Giovanni
    Cerchione, Claudio
    PANMINERVA MEDICA, 2021, 63 (01) : 1 - 6
  • [49] Vascular thromboembolic events in patients (pts) with advanced urothelial cancer (UC) treated with carboplatin/gemcitabine alone or in combination with bevacizumab
    Apolo, A. B.
    Regazzi, A. M.
    Milowsky, M. I.
    Bajorin, D. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [50] Thromboembolic events in gynecologic cancer patients treated with chemotherapy
    Zhang, Ran
    Stewart, Taylor
    Tetreault, Kaitlin
    Alexandridis, Roxana
    Bergsbaken, Jason
    Wallace, Sumer
    Kushner, David
    Hartenbach, Ellen
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S194 - S194
12345